FORZ (Forza Innovations) ROE % Adjusted to Book Value: Negative Equity% (As of Dec. 2023)


What is Forza Innovations ROE % Adjusted to Book Value?

Forza Innovations FORZ -99.00% ROE % Adjusted to Book Value is Negative Equity% as of Dec. 2023.

Forza Innovations's ROE % for the quarter that ended in Dec. 2023 was Negative Equity. Forza Innovations's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Forza Innovations's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was Negative Equity.

Forza Innovations ROE % Adjusted to Book Value Related Terms

Forza Innovations ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Forza Innovations's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forza Innovations ROE % Adjusted to Book Value Chart

Forza Innovations Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Forza Innovations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 Negative Equity

FORZ vs USAQ, EMED, RTSL: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Forza Innovations's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forza Innovations ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Forza Innovations's ROE % Adjusted to Book Value falls into.


Forza Innovations ROE % Adjusted to Book Value Calculation

Forza Innovations's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Forza Innovations's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of Negative Equity% mean?
Forza Innovations (FORZ) has a ROE % Adjusted to Book Value of Negative Equity% as of Dec. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Forza Innovations and its competitors.
Is Forza Innovations' ROE % Adjusted to Book Value too high?
Forza Innovations' current ROE % Adjusted to Book Value is Negative Equity%.
How does Forza Innovations' ROE % Adjusted to Book Value compare to USAQ and EMED?
Forza Innovations' ROE % Adjusted to Book Value of Negative Equity% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Forza Innovations and its competitors. Forza Innovations's current ROE % Adjusted to Book Value is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forza Innovations stock overvalued right now?
Forza Innovations (FORZ) has a current ROE % Adjusted to Book Value of Negative Equity%. The current ROE % Adjusted to Book Value is Negative Equity%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Forza Innovations (FORZ), the current ROE % Adjusted to Book Value is Negative Equity% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forza Innovations Business Description

Address 406 9th Avenue, Suite 210, San Diego, CA, USA, 92101
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.